PMDAX
Price
$19.20
Change
-$0.17 (-0.88%)
Updated
Sep 20 closing price
VMVAX
Price
$86.17
Change
-$0.37 (-0.43%)
Updated
Sep 20 closing price
Ad is loading...

PMDAX vs VMVAX

Header iconPMDAX vs VMVAX Comparison
Open Charts PMDAX vs VMVAXBanner chart's image
Principal Small-MidCap Dividend Inc A
Price$19.20
Change-$0.17 (-0.88%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$86.17
Change-$0.37 (-0.43%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
PMDAX vs VMVAX Comparison Chart
Loading...
VS
PMDAX vs. VMVAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMDAX is a Buy and VMVAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.5B vs. PMDAX (1.64B). VMVAX pays higher dividends than PMDAX: VMVAX (2.14) vs PMDAX (1.21). PMDAX was incepted earlier than VMVAX: PMDAX (13 years) vs VMVAX (13 years). PMDAX is a more actively managed with annual turnover of: 26.50 vs. VMVAX (22.00). PMDAX has a lower initial minimum investment than VMVAX: PMDAX (1000) vs VMVAX (3000). PMDAX (25.48) and VMVAX (25.35) have marching annual gain over last year. VMVAX return over 5 years is better than : 48.82 vs. PMDAX (38.02).
PMDAXVMVAXPMDAX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years13 years-
Gain YTD11.53014.94677%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets1.64B30.5B5%
Annual Yield % from dividends1.212.1457%
Returns for 1 year25.4825.35101%
Returns for 3 years21.4420.71104%
Returns for 5 years38.0248.8278%
Returns for 10 years64.20100.8864%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUUD0.790.01
+0.67%
Auddia
CTLT60.00-0.11
-0.18%
CATALENT
JAMF18.49-0.09
-0.48%
Jamf Holding Corp
ARCT20.61-0.41
-1.95%
Arcturus Therapeutics Holdings
ANVS8.47-0.17
-1.97%
Annovis Bio